806 related articles for article (PubMed ID: 30122154)
21. Facioscapulohumeral muscular dystrophy: molecular pathological advances and future directions.
Statland JM; Tawil R
Curr Opin Neurol; 2011 Oct; 24(5):423-8. PubMed ID: 21734574
[TBL] [Abstract][Full Text] [Related]
22. Loss of epigenetic silencing of the DUX4 transcription factor gene in facioscapulohumeral muscular dystrophy.
Hewitt JE
Hum Mol Genet; 2015 Oct; 24(R1):R17-23. PubMed ID: 26113644
[TBL] [Abstract][Full Text] [Related]
23. Facioscapulohumeral muscular dystrophy.
Tawil R
Handb Clin Neurol; 2018; 148():541-548. PubMed ID: 29478599
[TBL] [Abstract][Full Text] [Related]
24. Myogenic enhancers regulate expression of the facioscapulohumeral muscular dystrophy-associated DUX4 gene.
Himeda CL; Debarnot C; Homma S; Beermann ML; Miller JB; Jones PL; Jones TI
Mol Cell Biol; 2014 Jun; 34(11):1942-55. PubMed ID: 24636994
[TBL] [Abstract][Full Text] [Related]
25. Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene.
Snider L; Geng LN; Lemmers RJ; Kyba M; Ware CB; Nelson AM; Tawil R; Filippova GN; van der Maarel SM; Tapscott SJ; Miller DG
PLoS Genet; 2010 Oct; 6(10):e1001181. PubMed ID: 21060811
[TBL] [Abstract][Full Text] [Related]
26. Facioscapulohumeral Muscular Dystrophy.
DeSimone AM; Pakula A; Lek A; Emerson CP
Compr Physiol; 2017 Sep; 7(4):1229-1279. PubMed ID: 28915324
[TBL] [Abstract][Full Text] [Related]
27. Intronic
Goossens R; van den Boogaard ML; Lemmers RJLF; Balog J; van der Vliet PJ; Willemsen IM; Schouten J; Maggio I; van der Stoep N; Hoeben RC; Tapscott SJ; Geijsen N; Gonçalves MAFV; Sacconi S; Tawil R; van der Maarel SM
J Med Genet; 2019 Dec; 56(12):828-837. PubMed ID: 31676591
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous measurement of the size and methylation of chromosome 4qA-D4Z4 repeats in facioscapulohumeral muscular dystrophy by long-read sequencing.
Hiramuki Y; Kure Y; Saito Y; Ogawa M; Ishikawa K; Mori-Yoshimura M; Oya Y; Takahashi Y; Kim DS; Arai N; Mori C; Matsumura T; Hamano T; Nakamura K; Ikezoe K; Hayashi S; Goto Y; Noguchi S; Nishino I
J Transl Med; 2022 Nov; 20(1):517. PubMed ID: 36348371
[TBL] [Abstract][Full Text] [Related]
29. Identification of Epigenetic Regulators of DUX4-fl for Targeted Therapy of Facioscapulohumeral Muscular Dystrophy.
Himeda CL; Jones TI; Virbasius CM; Zhu LJ; Green MR; Jones PL
Mol Ther; 2018 Jul; 26(7):1797-1807. PubMed ID: 29759937
[TBL] [Abstract][Full Text] [Related]
30. Monosomy 18p is a risk factor for facioscapulohumeral dystrophy.
Balog J; Goossens R; Lemmers RJLF; Straasheijm KR; van der Vliet PJ; Heuvel AVD; Cambieri C; Capet N; Feasson L; Manel V; Contet J; Kriek M; Donlin-Smith CM; Ruivenkamp CAL; Heard P; Tapscott SJ; Cody JD; Tawil R; Sacconi S; van der Maarel SM
J Med Genet; 2018 Jul; 55(7):469-478. PubMed ID: 29563141
[TBL] [Abstract][Full Text] [Related]
31. CRISPR/dCas9-mediated Transcriptional Inhibition Ameliorates the Epigenetic Dysregulation at D4Z4 and Represses DUX4-fl in FSH Muscular Dystrophy.
Himeda CL; Jones TI; Jones PL
Mol Ther; 2016 Mar; 24(3):527-35. PubMed ID: 26527377
[TBL] [Abstract][Full Text] [Related]
32. Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD).
Zeng W; de Greef JC; Chen YY; Chien R; Kong X; Gregson HC; Winokur ST; Pyle A; Robertson KD; Schmiesing JA; Kimonis VE; Balog J; Frants RR; Ball AR; Lock LF; Donovan PJ; van der Maarel SM; Yokomori K
PLoS Genet; 2009 Jul; 5(7):e1000559. PubMed ID: 19593370
[TBL] [Abstract][Full Text] [Related]
33. Direct interplay between two candidate genes in FSHD muscular dystrophy.
Ferri G; Huichalaf CH; Caccia R; Gabellini D
Hum Mol Genet; 2015 Mar; 24(5):1256-66. PubMed ID: 25326393
[TBL] [Abstract][Full Text] [Related]
34. Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.
van der Maarel SM; Tawil R; Tapscott SJ
Trends Mol Med; 2011 May; 17(5):252-8. PubMed ID: 21288772
[TBL] [Abstract][Full Text] [Related]
35. PAX7 target gene repression is a superior FSHD biomarker than DUX4 target gene activation, associating with pathological severity and identifying FSHD at the single-cell level.
Banerji CRS; Zammit PS
Hum Mol Genet; 2019 Jul; 28(13):2224-2236. PubMed ID: 31067297
[TBL] [Abstract][Full Text] [Related]
36. The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1.
Sacconi S; Lemmers RJ; Balog J; van der Vliet PJ; Lahaut P; van Nieuwenhuizen MP; Straasheijm KR; Debipersad RD; Vos-Versteeg M; Salviati L; Casarin A; Pegoraro E; Tawil R; Bakker E; Tapscott SJ; Desnuelle C; van der Maarel SM
Am J Hum Genet; 2013 Oct; 93(4):744-51. PubMed ID: 24075187
[TBL] [Abstract][Full Text] [Related]
37. Wnt/β-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells.
Block GJ; Narayanan D; Amell AM; Petek LM; Davidson KC; Bird TD; Tawil R; Moon RT; Miller DG
Hum Mol Genet; 2013 Dec; 22(23):4661-72. PubMed ID: 23821646
[TBL] [Abstract][Full Text] [Related]
38. SMCHD1 regulates a limited set of gene clusters on autosomal chromosomes.
Mason AG; Slieker RC; Balog J; Lemmers RJLF; Wong CJ; Yao Z; Lim JW; Filippova GN; Ne E; Tawil R; Heijmans BT; Tapscott SJ; van der Maarel SM
Skelet Muscle; 2017 Jun; 7(1):12. PubMed ID: 28587678
[TBL] [Abstract][Full Text] [Related]
39. NuRD and CAF-1-mediated silencing of the D4Z4 array is modulated by DUX4-induced MBD3L proteins.
Campbell AE; Shadle SC; Jagannathan S; Lim JW; Resnick R; Tawil R; van der Maarel SM; Tapscott SJ
Elife; 2018 Mar; 7():. PubMed ID: 29533181
[TBL] [Abstract][Full Text] [Related]
40. Asymmetric bidirectional transcription from the FSHD-causing D4Z4 array modulates DUX4 production.
Block GJ; Petek LM; Narayanan D; Amell AM; Moore JM; Rabaia NA; Tyler A; van der Maarel SM; Tawil R; Filippova GN; Miller DG
PLoS One; 2012; 7(4):e35532. PubMed ID: 22536400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
